CHEPLAPHARM Arzneimittel GmbH

Private

GreifswaldHealthcare & Life Scienceshttps://www.cheplapharm.com/

Last Round

Debt

Feb 9, 2026

Total Funding Raised

$5.7B

Momentum

Quiet

No recent growth signals

Company Overview

CHEPLAPHARM Arzneimittel GmbH is a specialty pharmaceutical company that acquires and manages established, off-patent branded legacy and niche pharmaceutical products.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

pharmaceutical acquisitionoff-patent medicinesbranded genericslifecycle managementasset-light pharmacontract manufacturing organizationCMOtransitional service agreementTSApharmaceutical distributionlegacy drug portfoliospecialty pharmasupply chain managementregulatory compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CHEPLAPHARM Arzneimittel GmbH Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CHEPLAPHARM Arzneimittel GmbH Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Feb 9, 2026
Debt	Jul 2, 2025
Debt	May 10, 2023
Debt	May 10, 2023
Convertible Debt	Oct 25, 2022
Debt	Feb 11, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Alexander Jan Sosnitza

Referent CEO

Executive Team

Edeltraud Maria Lafer

Chief Executive Officer, Co-Chief Executive Officer

Executive Team

Sebastian Frank Braun

Major shareholder Chief Executive Officer

Executive Team

Kia Parssanedjad

Chief Financial Officer (CFO)

Executive Team

View all key people

CHEPLAPHARM Arzneimittel GmbH Investors

Notable investors and investment history

Investor	Rounds
GIC Private Limited	Convertible Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 2, 2025
$810M debt round completed.

View all signals

CHEPLAPHARM Arzneimittel GmbH Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CHEPLAPHARM Arzneimittel GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CHEPLAPHARM Arzneimittel GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreifswald

Employee Range498

Year Founded1998

Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.